Home » Topics » Conferences

Conferences
RSS

5-ht6 receptor function under study at SmithKline Beecham

Aug. 31, 1999

DuPont team presents new cdk inhibitors at ACS meeting

Aug. 31, 1999

ETA antagonist TA-0201 protects against deleterious effects of MI in dogs

Aug. 31, 1999

ME-3230, an orally active prodrug of a potent gpIIb/IIIa antagonist

Aug. 31, 1999

Preclinical and mechanism of action studies support efficacy of the NHE-1 inhibitor cariporide

Aug. 31, 1999

U of M research team studies new compounds for imaging prostate cancer

Aug. 30, 1999

Final results of REACH-1 now in, support efficacy of bosentan in CHF

Aug. 30, 1999

LB-42908 inhibits protein farnesyltransferase in vitro, in vivo

Aug. 30, 1999

News from ACS: hepatitis C viral protease inhibitor BILN-303-SE

Aug. 30, 1999

Still in the news: vasopeptidase inhibitor omapatrilat a protagonist in Barcelona

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...